Answers are grounded in this paper and cite their sources.
This analysis identifies PMAPscore as a reliable biomarker predicting outcomes in advanced gastric cancer, suggesting improved treatment strategies.
The PMAPscore-based risk model is a robust tool for predicting survival and immunotherapy responses in patients with advanced GC, supporting its clinical application for treatment stratification.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: